Thryvv : ratio page

SMS Lifesciences

Overview Articles News Financials Ratios Shareholding Peers

Financial Ratios

View
Order
Financial Ratios
Mar2024
Mar2023
Mar2022
Mar2021
Mar2020
Valuation Parameters:
PE(x)
22.57
13.71
8.30
11.04
5.20
PCE(x)
9.65
7.09
5.95
6.99
2.93
Price/Book(x)
1.16
0.93
1.38
1.16
0.46
Yield(%)
0.22
0.29
0.22
0.30
0.00
EV/Net Sales(x)
0.99
0.80
0.81
0.76
0.42
EV/Core EBITDA(x)
8.60
7.88
7.80
6.33
3.94
EV/EBIT(x)
14.99
10.72
7.26
8.39
5.50
EV/CE(x)
1.10
0.94
0.78
0.66
0.43
MCap / Sales
0.67
0.50
0.60
0.56
0.20
Growth Ratio:
Net Sales Growth(%)
-3.04
-9.86
31.81
1.84
-30.98
Core EBITDA Growth(%)
9.88
-12.07
13.25
15.71
-25.74
EBIT Growth(%)
-14.28
-39.78
61.21
21.94
-35.85
PAT Growth(%)
-44.38
-55.03
86.62
33.13
-42.94
EPS Growth(%)
-20.68
-54.73
86.79
33.13
-42.94
Financial Stability Ratios:
Total Debt/Equity(x)
0.55
0.59
0.51
0.50
0.55
Current Ratio(x)
1.07
1.19
1.14
1.10
1.22
Quick Ratio(x)
0.53
0.56
0.55
0.58
0.51
Interest Cover(x)
1.96
3.42
6.26
5.26
3.85
Total Debt/Mcap(x)
0.48
0.63
0.37
0.43
1.20
Operational & Financial Ratios:
Earnings Per Share (Rs)
30.08
37.91
83.76
44.84
33.68
CEPS(Rs)
70.34
73.32
116.78
70.84
59.69
DPS(Rs)
1.50
1.50
1.50
1.50
0.00
Book NAV/Share(Rs)
584.84
557.71
503.53
427.40
382.80
Tax Rate(%)
35.74
31.43
22.70
30.72
30.58
Margin Ratios:
Core EBITDA Margin(%)
9.21
8.05
8.88
10.25
8.74
EBIT Margin(%)
5.93
6.55
10.02
8.19
6.82
Pre Tax Margin(%)
2.90
4.63
8.42
6.63
5.05
PAT Margin (%)
1.87
3.18
6.51
4.59
3.51
Cash Profit Margin (%)
6.27
6.19
9.08
7.26
6.21
Performance Ratios:
ROA(%)
1.60
2.98
7.54
4.82
3.83
ROE(%)
3.66
7.09
17.98
11.07
9.17
ROCE(%)
7.42
9.44
18.42
12.96
11.91
Asset Turnover(x)
0.85
0.94
1.16
1.05
1.09
Sales/Fixed Asset(x)
1.19
1.56
2.28
1.88
2.04
Working Capital/Sales(x)
31.65
14.02
18.89
24.17
14.39
Efficiency Ratios:
Fixed Capital/Sales(x)
0.84
0.64
0.44
0.53
0.49
Receivable days
52.44
40.71
31.92
34.48
39.53
Inventory Days
90.14
87.15
68.75
77.87
91.38
Payable days
143.42
146.47
135.85
154.56
169.86